The rivalry between Moderna and Pfizer/BioNTech in commercialising their COVID-19 vaccines has now spilled over into the courts, in the form of a patent infringement lawsuit.

Pfizer’s JAK/TEC inhibitor Litfulo has been recommended for NHS use as a treatment for hair loss caused by severe alopecia areata, the first drug therapy for a condition that affects around ...

Bonus Sep 11, 1995 Oct 04, 1995 Sep 08, 1995 Bonus Ratio: 1 share(s) for every 1 shares held Rights Dec 18, 1992 Jan 15, 1993 Sep 30, 1993 Rights ratio: 2 share for every 5 held at a price of Rs 35.0 ...